Given that mounting studies have suggested that GLS1 inhibition or blocking ASNS in combination with asparaginase treatment is effective in attenuating tumor growth, targeting GLS1 and ASNS could be promising therapeutic strategies to suppress cancer progression through impairing angiogenesis. This evidence concerns the gene GLS and cancer.